Bcl-xS/L Antibodies

Santa Cruz Biotechnology delivers a wide array of Bcl-xS/L monoclonal antibodies for research in apoptosis and cell survival pathways. Bcl-xS/L Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Bcl-xS and Bcl-xL are critical regulators of the apoptotic process, with Bcl-xL promoting cell survival and Bcl-xS acting as a pro-apoptotic factor. Understanding the balance between Bcl-xS and Bcl-xL isoforms is essential for elucidating mechanisms of cancer progression and treatment resistance. The study of Bcl-xS/L is significant in neurodegenerative diseases, where dysregulation of apoptosis plays a key role. Researchers can explore the complex interactions between Bcl-xS and Bcl-xL to better understand their roles in cell death and survival. Investigating the expression patterns of Bcl-xS/L provides valuable insights into disease mechanisms and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cellular processes and contribute to the development of new therapeutic strategies.